{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:09:42Z","timestamp":1791284982728,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"BIO-NMD","award":["241665"],"award-info":[{"award-number":["241665"]}]},{"name":"Neuromics","award":["305121"],"award-info":[{"award-number":["305121"]}]},{"name":"RD-Connect","award":["305444"],"award-info":[{"award-number":["305444"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00415-016-8379-6","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T11:01:51Z","timestamp":1484046111000},"page":"541-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Reduced serum myostatin concentrations associated with genetic muscle disease progression"],"prefix":"10.1007","volume":"264","author":[{"given":"Peter M.","family":"Burch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Pogoryelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Palandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Fitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Marini","family":"Bettolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Neubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"8379_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nmd.2014.03.006","volume":"24","author":"A Aartsma-Rus","year":"2014","unstructured":"Aartsma-Rus A, Ferlini A, Vroom E (2014) Biomarkers and surrogate endpoints in Duchenne: meeting report. Neuromuscul Disord NMD 24:743\u2013745","journal-title":"Neuromuscul Disord NMD"},{"key":"8379_CR2","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.3390\/molecules200611154","volume":"20","author":"MA Anaya-Segura","year":"2015","unstructured":"Anaya-Segura MA, Garcia-Martinez FA, Montes-Almanza LA, Diaz BG, Avila-Ramirez G, Alvarez-Maya I, Coral-Vazquez RM, Mondragon-Teran P, Escobar-Cedillo RE, Garcia-Calderon N, Vazquez-Cardenas NA, Garcia S, Lopez-Hernandez LB (2015) Non-invasive biomarkers for duchenne muscular dystrophy and carrier detection. Molecules (Basel, Switzerland) 20:11154\u201311172","journal-title":"Molecules (Basel, Switzerland)"},{"key":"8379_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2008.01.024","volume":"391","author":"H Awano","year":"2008","unstructured":"Awano H, Takeshima Y, Okizuka Y, Saiki K, Yagi M, Matsuo M (2008) Wide ranges of serum myostatin concentrations in duchenne muscular dystrophy patients. Clin Chim Acta 391:115\u2013117","journal-title":"Clin Chim Acta"},{"key":"8379_CR4","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15252\/emmm.201303724","volume":"6","author":"B Ayoglu","year":"2014","unstructured":"Ayoglu B, Chaouch A, Lochm\u00fcller H, Politano L, Bertini E, Spitali P, Hiller M, Niks EH, Gualandi F, Pont\u00e9n F, Bushby K, Aartsma-Rus A, Schwartz E, Le Priol Y, Straub V, Uhlen M, Cirak S, 't Hoen PA, Muntoni F, Ferlini A, Schwenk JM, Nilsson P, Al-Khalili Szigyarto C (2014) Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO mol med 6:918\u2013936","journal-title":"EMBO mol med"},{"key":"8379_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","volume":"5","author":"HR Bergen 3rd","year":"2015","unstructured":"Bergen HR 3rd, Farr JN, Vanderboom PM, Atkinson EJ, White TA, Singh RJ, Khosla S, LeBrasseur NK (2015) Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skelet Muscle 5:21","journal-title":"Skelet Muscle"},{"key":"8379_CR6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418\u2013421","journal-title":"Nature"},{"key":"8379_CR7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbadis.2014.08.007","volume":"1852","author":"A Broccolini","year":"2015","unstructured":"Broccolini A, Mirabella M (2015) Hereditary inclusion-body myopathies. Biochim Biophys Acta 1852:644\u2013650","journal-title":"Biochim Biophys Acta"},{"key":"8379_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JND-140066","volume":"2","author":"PM Burch","year":"2015","unstructured":"Burch PM, Pogoryelova O, Goldstein R, Bennett D, Guglieri M, Straub V, Bushby K, Lochmuller H, Morris C (2015) Muscle-derived proteins as serum biomarkers for monitoring disease progression in three forms of muscular dystrophy. J Neuromuscul Dis 2:241\u2013255","journal-title":"J Neuromuscul Dis"},{"key":"8379_CR9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0960-8966(97)00107-7","volume":"7","author":"KE Davies","year":"1997","unstructured":"Davies KE (1997) Challenges in Duchenne muscular dystrophy. Neuromuscul Disord NMD 7:482\u2013486","journal-title":"Neuromuscul Disord NMD"},{"key":"8379_CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0032-1329199","volume":"32","author":"KM Flanigan","year":"2012","unstructured":"Flanigan KM (2012) The muscular dystrophies. Semin Neurol 32:255\u2013263","journal-title":"Semin Neurol"},{"key":"8379_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-08-045031-5.00006-2","volume":"101","author":"E Gallardo","year":"2011","unstructured":"Gallardo E, Saenz A, Illa I (2011) Limb-girdle muscular dystrophy 2A. Hand Clin Neurol 101:97\u2013110","journal-title":"Hand Clin Neurol"},{"key":"8379_CR12","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2015","unstructured":"Hathout Y, Brody E, Clemens PR, Cripe L, DeLisle RK, Furlong P, Gordish-Dressman H, Hache L, Henricson E, Hoffman EP, Kobayashi YM, Lorts A, Mah JK, McDonald C, Mehler B, Nelson S, Nikrad M, Singer B, Steele F, Sterling D, Sweeney HL, Williams S, Gold L (2015) Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 112:7153\u20137158","journal-title":"Proc Natl Acad Sci USA"},{"key":"8379_CR13","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.1074\/jbc.M206379200","volume":"277","author":"JJ Hill","year":"2002","unstructured":"Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735\u201340741","journal-title":"J Biol Chem"},{"key":"8379_CR14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1210\/me.2002-0366","volume":"17","author":"JJ Hill","year":"2003","unstructured":"Hill JJ, Qiu Y, Hewick RM, Wolfman NM (2003) Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol (Baltimore, Md) 17:1144\u20131154","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"key":"8379_CR15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coph.2006.11.011","volume":"7","author":"D Joulia-Ekaza","year":"2007","unstructured":"Joulia-Ekaza D, Cabello G (2007) The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 7:310\u2013315","journal-title":"Curr Opin Pharmacol"},{"key":"8379_CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","volume":"302","author":"KM Lakshman","year":"2009","unstructured":"Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, Tchistiakova L, Forlow SB, St Ledger K, Burczynski ME, Dorner AJ, Lavallie ER (2009) Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol 302:26\u201332","journal-title":"Mol Cell Endocrinol"},{"key":"8379_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2990.2004.00555.x","volume":"30","author":"SH Laval","year":"2004","unstructured":"Laval SH, Bushby KM (2004) Limb-girdle muscular dystrophies\u2013from genetics to molecular pathology. Neuropathol Appl Neurobiol 30:91\u2013105","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8379_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","volume":"23","author":"JR Mendell","year":"2015","unstructured":"Mendell JR, Sahenk Z, Malik V, Gomez AM, Flanigan KM, Lowes LP, Alfano LN, Berry K, Meadows E, Lewis S, Braun L, Shontz K, Rouhana M, Clark KR, Rosales XQ, Al-Zaidy S, Govoni A, Rodino-Klapac LR, Hogan MJ, Kaspar BK (2015) A phase 1\/2a follistatin gene therapy trial for becker muscular dystrophy. Mol Ther J Am Soc Gene Ther 23:192\u2013201","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"8379_CR19","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1177\/0363546513490651","volume":"41","author":"CL Mendias","year":"2013","unstructured":"Mendias CL, Lynch EB, Davis ME, Enselman ERS, Harning JA, DeWolf PD, Makki TA, Bedi A (2013) Changes in circulating biomarkers of muscle atrophy, inflammation and cartilage turnover in patients undergoing anterior cruciate ligament reconstruction and rehabilitation. Am J Sports Med 41:1819\u20131826","journal-title":"Am J Sports Med"},{"key":"8379_CR20","doi-asserted-by":"crossref","first-page":"e9176","DOI":"10.1371\/journal.pone.0009176","volume":"5","author":"KJ Morine","year":"2010","unstructured":"Morine KJ, Bish LT, Pendrak K, Sleeper MM, Barton ER, Sweeney HL (2010) Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice. PLoS One 5:e9176","journal-title":"PLoS One"},{"key":"8379_CR21","first-page":"477","volume":"22","author":"M Nakatani","year":"2008","unstructured":"Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K (2008) Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J Off Publ Fed Am Soc Exp Biol 22:477\u2013487","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"8379_CR22","first-page":"110","volume":"31","author":"G Nigro","year":"2012","unstructured":"Nigro G, Papa AA, Politano L (2012) The heart and cardiac pacing in Steinert disease. Acta Myologica 31:110\u2013116","journal-title":"Acta Myologica"},{"key":"8379_CR23","first-page":"1","volume":"33","author":"V Nigro","year":"2014","unstructured":"Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol Myopathies Card Off J Mediterr Soc Myol 33:1\u201312 (edited by the Gaetano Conte Academy for the study of striated muscle diseases)","journal-title":"Acta Myol Myopathies Card Off J Mediterr Soc Myol"},{"key":"8379_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006974613418","volume":"190","author":"E Ozawa","year":"1999","unstructured":"Ozawa E, Hagiwara Y, Yoshida M (1999) Creatine kinase, cell membrane and Duchenne muscular dystrophy. Mol Cell Biochem 190:143\u2013151","journal-title":"Mol Cell Biochem"},{"key":"8379_CR25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/prca.201500112","volume":"10","author":"J Palandra","year":"2016","unstructured":"Palandra J, Quazi A, Fitz L, Rong H, Morris C, Neubert H (2016) Quantitative measurements of GDF-8 using immunoaffinity LC-MS\/MS. Proteom Clin Appl 10:597\u2013604","journal-title":"Proteom Clin Appl"},{"key":"8379_CR26","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1111\/febs.12267","volume":"280","author":"TA Partridge","year":"2013","unstructured":"Partridge TA (2013) The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J 280:4177\u20134186","journal-title":"FEBS J"},{"key":"8379_CR27","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1164\/ajrccm.164.12.2103052","volume":"164","author":"MF Phillips","year":"2001","unstructured":"Phillips MF, Quinlivan RC, Edwards RH, Calverley PM (2001) Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 164:2191\u20132194","journal-title":"Am J Respir Crit Care Med"},{"key":"8379_CR28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/gerona\/glr025","volume":"66","author":"A Ratkevicius","year":"2011","unstructured":"Ratkevicius A, Joyson A, Selmer I, Dhanani T, Grierson C, Tommasi AM, DeVries A, Rauchhaus P, Crowther D, Alesci S, Yaworsky P, Gilbert F, Redpath TW, Brady J, Fearon KC, Reid DM, Greig CA, Wackerhage H (2011) Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. J Gerontol Ser A Biol Sci Med Sci 66:620\u2013626","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"8379_CR29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jnnp-2016-315106.142","volume":"87","author":"V Ricotti","year":"2016","unstructured":"Ricotti V, Ridout DA, Pane M, Main M, Mayhew A, Mercuri E, Manzur AY, Muntoni F (2016) The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials. J Neurol Neurosurg Psychiatry 87:149\u2013155","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8379_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/WCO.0b013e328364fbaf","volume":"26","author":"UT Ruegg","year":"2013","unstructured":"Ruegg UT (2013) Pharmacological prospects in the treatment of Duchenne muscular dystrophy. Curr Opin Neurol 26:577\u2013584","journal-title":"Curr Opin Neurol"},{"key":"8379_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mce.2009.12.019","volume":"317","author":"A Saremi","year":"2010","unstructured":"Saremi A, Gharakhanloo R, Sharghi S, Gharaati MR, Larijani B, Omidfar K (2010) Effects of oral creatine and resistance training on serum myostatin and GASP-1. Mol Cell Endocrinol 317:25\u201330","journal-title":"Mol Cell Endocrinol"},{"key":"8379_CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tem.2014.06.002","volume":"25","author":"R Sartori","year":"2014","unstructured":"Sartori R, Gregorevic P, Sandri M (2014) TGFbeta and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol Metab Tem 25:464\u2013471","journal-title":"Trends Endocrinol Metab Tem"},{"key":"8379_CR33","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","volume":"350","author":"M Schuelke","year":"2004","unstructured":"Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Eng J Med 350:2682\u20132688","journal-title":"N Eng J Med"},{"key":"8379_CR34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mus.24163","volume":"50","author":"C Spurney","year":"2014","unstructured":"Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR (2014) Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50:250\u2013256","journal-title":"Muscle Nerve"},{"key":"8379_CR35","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2012-1273","volume":"97","author":"P Szulc","year":"2012","unstructured":"Szulc P, Schoppet M, Goettsch C, Rauner M, Dschietzig T, Chapurlat R, Hofbauer LC (2012) Endocrine and clinical correlates of myostatin serum concentration in men\u2013the STRAMBO study. J Clin Endocrinol Metab 97:3700\u20133708","journal-title":"J Clin Endocrinol Metab"},{"key":"8379_CR36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","volume":"32","author":"CA Thornton","year":"2014","unstructured":"Thornton CA (2014) Myotonic dystrophy. Neurologic clinics 32:705\u2013719 (viii)","journal-title":"Neurologic clinics"},{"key":"8379_CR37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.coph.2005.01.011","volume":"5","author":"JF Tobin","year":"2005","unstructured":"Tobin JF, Celeste AJ (2005) Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases. Curr Opin Pharmacol 5:328\u2013332","journal-title":"Curr Opin Pharmacol"},{"key":"8379_CR38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","volume":"63","author":"KR Wagner","year":"2008","unstructured":"Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR (2008) A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63:561\u2013571","journal-title":"Ann Neurol"},{"key":"8379_CR39","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/CIRCRESAHA.116.308391","volume":"118","author":"RG Walker","year":"2016","unstructured":"Walker RG, Poggioli T, Katsimpardi L, Buchanan SM, Oh J, Wattrus S, Heidecker B, Fong YW, Rubin LL, Ganz P, Thompson TB, Wagers AJ, Lee RT (2016) Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation. Circ Res 118:1125\u20131142","journal-title":"Circ Res"},{"key":"8379_CR40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-8-26","volume":"8","author":"MC Walter","year":"2013","unstructured":"Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Muller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochmuller H (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8:26","journal-title":"Orphanet J Rare Dis"},{"key":"8379_CR41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-016-0667-0","volume":"16","author":"LH Wang","year":"2016","unstructured":"Wang LH, Tawil R (2016) Facioscapulohumeral dystrophy. Curr Neurol Neurosci Rep 16:66","journal-title":"Curr Neurol Neurosci Rep"},{"key":"8379_CR42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000356740","volume":"60","author":"TA White","year":"2014","unstructured":"White TA, LeBrasseur NK (2014) Myostatin and sarcopenia: opportunities and challenges\u2014a mini-review. Gerontology 60:289\u2013293","journal-title":"Gerontology"},{"key":"8379_CR43","first-page":"343","volume":"6","author":"KE Yarasheski","year":"2002","unstructured":"Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF (2002) Serum myostatin-immunoreactive protein is increased in 60\u201392\u00a0year old women and men with muscle wasting. J Nutr Health Aging 6:343\u2013348","journal-title":"J Nutr Health Aging"},{"key":"8379_CR44","doi-asserted-by":"crossref","first-page":"e80263","DOI":"10.1371\/journal.pone.0080263","volume":"8","author":"IT Zaharieva","year":"2013","unstructured":"Zaharieva IT, Calissano M, Scoto M, Preston M, Cirak S, Feng L, Collins J, Kole R, Guglieri M, Straub V, Bushby K, Ferlini A, Morgan JE, Muntoni F (2013) Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy. PLoS One 8:e80263","journal-title":"PLoS One"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8379-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T10:18:44Z","timestamp":1568715524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["8379"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8379-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}